Immunotherapies (IT) require induction, expansion, and maintenance of specific changes to a patient's immune cell repertoire which yield a therapeutic benefit. Recently, mechanistic understanding of these changes at the cellular level has revealed that IT results in complex phenotypic transitions in target cells, and that therapeutic effectiveness may be predicted by monitoring these transitions during therapy. However, monitoring will require unique tools that enable capture, manipulation, and profiling of rare immune cell populations. In this study, we introduce a method of automated and unsupervised separation and processing of rare immune cells, using high-force and multidimensional magnetic ratcheting (MR). We demonstrate capture of ta...
Simultaneous cell profiling and isolation based on cellular antigen-binding capacity plays an import...
T cells are key mediators of adaptive immunity. However, the overall immune response is often di...
The cancer community continues to search for an efficient and cost-effective technique to isolate an...
Extraction of rare target cells from biosamples is enabling for life science research. Traditional r...
Progress in clinical trials in infectious disease, autoimmunity, and cancer is stymied by a dearth o...
Rapid and accurate detection, quantification and analysis of rare cells in biological samples is of ...
Background: Progress in clinical trials in infectious disease, autoimmunity, and cancer is stymied b...
Recent studies have shown that specific rare cells in the blood can serve as an indicator of cancer ...
Adoptive cell therapies taking advantage of engineered Chimeric Antigen Receptors (CAR) or T-Cell Re...
Background: detailed information about circulating tumor cells (CTCs) as an indicator of therapy res...
Abstract Background Rare nucle...
A major parameter limiting immune responses to vaccination is the number of activated antigen-presen...
A one-step immunomagnetic separation technique was performed on a microfluidic platform for the isol...
No T cell receptor (TCR) T cell therapies have obtained clinical approval. The lack of strategies ca...
Neoantigen-specific T cells are increasingly viewed as important immunotherapy effectors, but physic...
Simultaneous cell profiling and isolation based on cellular antigen-binding capacity plays an import...
T cells are key mediators of adaptive immunity. However, the overall immune response is often di...
The cancer community continues to search for an efficient and cost-effective technique to isolate an...
Extraction of rare target cells from biosamples is enabling for life science research. Traditional r...
Progress in clinical trials in infectious disease, autoimmunity, and cancer is stymied by a dearth o...
Rapid and accurate detection, quantification and analysis of rare cells in biological samples is of ...
Background: Progress in clinical trials in infectious disease, autoimmunity, and cancer is stymied b...
Recent studies have shown that specific rare cells in the blood can serve as an indicator of cancer ...
Adoptive cell therapies taking advantage of engineered Chimeric Antigen Receptors (CAR) or T-Cell Re...
Background: detailed information about circulating tumor cells (CTCs) as an indicator of therapy res...
Abstract Background Rare nucle...
A major parameter limiting immune responses to vaccination is the number of activated antigen-presen...
A one-step immunomagnetic separation technique was performed on a microfluidic platform for the isol...
No T cell receptor (TCR) T cell therapies have obtained clinical approval. The lack of strategies ca...
Neoantigen-specific T cells are increasingly viewed as important immunotherapy effectors, but physic...
Simultaneous cell profiling and isolation based on cellular antigen-binding capacity plays an import...
T cells are key mediators of adaptive immunity. However, the overall immune response is often di...
The cancer community continues to search for an efficient and cost-effective technique to isolate an...